glp-1 gi obstruction lawsuit in kentucky class action kentucky glp-1 gastrointestinal obstruction class action GLP-1 kentucky semaglutide gi obstruction law

Finally, patient education remains a cornerstone of success

Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and patients with type 2 diabetes using exendin [939] as a GLP-1 receptor antagonist

Lilly is sprinting through an obesity gold rush

GLP-1 agonists are most often used by people with type 2 diabetes to manage blood sugar levels, but in recent years, theyve become a top treatment choice for people with overweight or obesity for weight management

It could trap many families in a cycle of poor health and high medical costs

This is an evolving field, and what's described here reflects the best available human evidence as of 2025, not a decades-long consensus